Cargando…

Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer

INTRODUCTION: Cyclin-dependent kinase (CDK)4/6 inhibitor is a first-line therapy for metastatic ER+/HER2-breast cancer. However, there are limited data on safety of combined radiotherapy (RT) and CDK4/6 inhibition. METHODS: We conducted a retrospective study of women with metastatic breast cancer wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Kristine N., Shah, Payal, Clark, Amy, Freedman, Gary M., Dastgheyb, Sana, Barsky, Andrew R., Dreyfuss, Alexandra D., Taunk, Neil K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527028/ https://www.ncbi.nlm.nih.gov/pubmed/34653725 http://dx.doi.org/10.1016/j.breast.2021.10.001

Ejemplares similares

Acute skin radiation toxicity seen with concurrent T-DM1: A single institutional report of 35 patients
por: Dastgheyb, Sana Sara, et al.
Publicado: (2022)

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
por: LaRiviere, Michael J., et al.
Publicado: (2021)

Initial Clinical Experience Treating Patients With Gynecologic Cancers on a 6MV Flattening Filter Free O-Ring Linear Accelerator
por: Barsky, Andrew R., et al.
Publicado: (2020)

Initial Clinical Experience Treating Patients with Breast Cancer on a 6-MV Flattening-Filter-Free O-Ring Linear Accelerator
por: Barsky, Andrew R., et al.
Publicado: (2019)

Stereotactic Radiation for Oligometastatic and Oligoprogressive Stage IV Breast Cancer: A Case-based Review
por: Freedman, Gary M., et al.
Publicado: (2023)

Palliative Radiation Therapy for Metastatic, Persistent, or Recurrent Epithelial Ovarian Cancer: Efficacy in the Era of Modern Technology and Targeted Agents
por: Butala, Anish A., et al.
Publicado: (2020)

Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot
por: Lee, Anna, et al.
Publicado: (2021)

First-ever Abscopal Effect after Palliative Radiotherapy and Immuno-gene Therapy for Malignant Pleural Mesothelioma
por: Barsky, Andrew R, et al.
Publicado: (2019)

The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision
por: Xu, Biaoxiang, et al.
Publicado: (2022)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

Role of the Combination of Cyclin-Dependent Kinase Inhibitors (CDKI) and Radiotherapy (RT) in the Treatment of Metastatic Breast Cancer (MBC): Advantages and Risks in Clinical Practice
por: Gagliano, Ambrogio, et al.
Publicado: (2021)

Palliative radiotherapy
por: Spencer, Katie, et al.
Publicado: (2018)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
por: Javed, Aadil, et al.
Publicado: (2023)

Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia
por: Kim, Juri, et al.
Publicado: (2023)

Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer
por: Bae, Sun Hyun, et al.
Publicado: (2011)

Patterns of Palliative Radiotherapy Utilization for Patients With Metastatic Breast Cancer in Harare, Zimbabwe
por: Mushonga, Melinda, et al.
Publicado: (2021)

Cyclin-dependent kinase 4/6 inhibition in cancer therapy
por: Johnson, Neil, et al.
Publicado: (2012)

Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?
por: Wright, Christopher M., et al.
Publicado: (2022)

Review of cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer
por: Husinka, Lakyn, et al.
Publicado: (2020)

The Palliative Care in the Metastatic Spinal Tumors. A Systematic Review on the Radiotherapy and Surgical Perspective
por: Giammalva, Giuseppe Roberto, et al.
Publicado: (2022)

Cyclin-dependent kinases in C. elegans
por: Boxem, Mike
Publicado: (2006)

Cyclin kinase inhibitors and interferons in lupus
por: Theofilopoulos, A
Publicado: (2003)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Simultaneous Multiple Liver Metastasis Treated with Pencil Beam Proton Stereotactic Body Radiotherapy (SBRT)
por: Taunk, Neil K., et al.
Publicado: (2021)

Increase in Superficial Dose in Whole-Breast Irradiation With Halcyon Straight-Through Linac Compared With Traditional C-arm Linac With Flattening Filter: In vivo Dosimetry and Planning Study
por: O'Grady, Fionnbarr, et al.
Publicado: (2019)

The Evolving Practice of Palliative Radiotherapy
por: Rembielak, A., et al.
Publicado: (2020)

An easy tool to predict survival in patients with bone metastatic lung cancer treated with palliative radiotherapy
por: Makita, Kenji, et al.
Publicado: (2023)

Whole Breast Irradiation with Halcyon™ 2.0: Workflow and Efficiency of Field-in-Field Treatment with Dynamic Beam Flattening Technique and kV Cone Beam Computed Tomography
por: Kennedy, Chris, et al.
Publicado: (2018)

Feasibility of Fewer Fraction Palliative Radiotherapy in Resource-Limited Setting
por: Dulal, Soniya, et al.
Publicado: (2020)

Phosphorylation of cyclin O, a novel cyclin family protein containing a cyclin-like domain, is involved in the activation of cyclin-dependent kinase 2
por: KIM, DO HYUNG, et al.
Publicado: (2014)

The Cyclin-Dependent Kinase Ortholog pUL97 of Human Cytomegalovirus Interacts with Cyclins
por: Graf, Laura, et al.
Publicado: (2013)

Deciphering the binding behavior of flavonoids to the cyclin dependent kinase 6/cyclin D complex
por: Zhang, Jingxiao, et al.
Publicado: (2018)

Cyclin A triggers Mitosis either via the Greatwall kinase pathway or Cyclin B
por: Hégarat, Nadia, et al.
Publicado: (2020)

Concomitant Presence of p16/Cyclin‐dependent Kinase 4 and Cyclin D/Cyclin‐dependent Kinase 4 omplexes in LNCaP Prostatic Cancer Cell Line
por: Itoh, Noriyuki, et al.
Publicado: (1997)

Adverse Cardiovascular Events Associated With Cyclin‐Dependent Kinase 4/6 Inhibitors in Patients With Metastatic Breast Cancer
por: Fradley, Michael G., et al.
Publicado: (2023)

Prediction of Cyclin-Dependent Kinase Phosphorylation Substrates
por: Chang, Emmanuel J., et al.
Publicado: (2007)

Kinase independent oncogenic cyclin D1
por: Casimiro, Mathew C., et al.
Publicado: (2015)

Cyclin-dependent kinase control of motile ciliogenesis
por: Vladar, Eszter K, et al.
Publicado: (2018)

Cyclin-dependent kinases and rare developmental disorders
por: Colas, Pierre
Publicado: (2020)

Therapeutic targeting of transcriptional cyclin-dependent kinases
por: Galbraith, Matthew D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rs6cuat5v3ae51nj06fmtndfhu